-
Je něco špatně v tomto záznamu ?
Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure
H. Kolesova, P. Hrabalova, R. Bohuslavova, P. Abaffy, V. Fabriciova, D. Sedmera, G. Pavlinkova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- dítě MeSH
- faktor 1 indukovatelný hypoxií - podjednotka alfa metabolismus MeSH
- gestační diabetes * metabolismus MeSH
- kardiovaskulární nemoci * metabolismus MeSH
- lidé MeSH
- myokard metabolismus MeSH
- myši MeSH
- novorozenec MeSH
- srdce MeSH
- srdeční selhání * MeSH
- těhotenství MeSH
- zvířata MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- myši MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood. METHODS AND RESULTS: In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population. DISCUSSION: Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.
Faculty of Science Charles University Prague Czechia
Institute of Anatomy 1st Faculty of Medicine Charles University Prague Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006788
- 003
- CZ-PrNML
- 005
- 20240624143236.0
- 007
- ta
- 008
- 240412e20240305sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fendo.2024.1344074 $2 doi
- 035 __
- $a (PubMed)38505753
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kolesova, Hana $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czechia $u Department of Developmental Cardiology, Institute of Physiology Czech Academy of Sciences (CAS), Prague, Czechia
- 245 10
- $a Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure / $c H. Kolesova, P. Hrabalova, R. Bohuslavova, P. Abaffy, V. Fabriciova, D. Sedmera, G. Pavlinkova
- 520 9_
- $a INTRODUCTION: Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood. METHODS AND RESULTS: In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population. DISCUSSION: Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a těhotenství $7 D011247
- 650 12
- $a kardiovaskulární nemoci $x metabolismus $7 D002318
- 650 12
- $a gestační diabetes $x metabolismus $7 D016640
- 650 _2
- $a srdce $7 D006321
- 650 12
- $a srdeční selhání $7 D006333
- 650 _2
- $a myokard $x metabolismus $7 D009206
- 650 _2
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hrabalova, Petra $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia $u Faculty of Science, Charles University, Prague, Czechia
- 700 1_
- $a Bohuslavova, Romana $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
- 700 1_
- $a Abaffy, Pavel $u Laboratory of Gene Expression, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
- 700 1_
- $a Fabriciova, Valeria $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia
- 700 1_
- $a Sedmera, David $u Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czechia $u Department of Developmental Cardiology, Institute of Physiology Czech Academy of Sciences (CAS), Prague, Czechia
- 700 1_
- $a Pavlínková, Gabriela, $u Laboratory of Molecular Pathogenetics, Institute of Biotechnology Czech Academy of Sciences (CAS), BIOCEV, Vestec, Czechia $d 1966- $7 xx0319150
- 773 0_
- $w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 15 (20240305), s. 1344074
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38505753 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240624143234 $b ABA008
- 999 __
- $a ok $b bmc $g 2081023 $s 1216555
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1344074 $e 20240305 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
- LZP __
- $a Pubmed-20240412